Rate of severe maternal morbidity 292.1 per 10,000 live births among those with OUD, with variation seen across states
WEDNESDAY, Jan. 8, 2025 (HealthDay News) — The rate of opioid use disorder (OUD) is high in Medicaid-enrolled pregnant women, and they have a high rate of severe maternal morbidity (SMM), according to a study published online Jan. 7 in JAMA Network Open.
Samantha G. Auty, Ph.D., from the Boston University School of Public Health, and colleagues identified 96,309 pregnant women with OUD enrolled in Medicaid in 47 states with 108,975 deliveries in a cross-sectional study to estimate the rates of SMM.
The researchers found that across states, the mean rate of OUD among pregnant women enrolled in Medicaid was 324.8 per 10,000 live births. In this group, the mean unadjusted rate of SMM, excluding blood transfusions, among those with OUD was 292.1 per 10,000 live births, with substantial variation seen across states from 101.0 to 682.2 per 10,000 live births in South Dakota and California, respectively. The estimated rate of SMM was not meaningfully altered with adjustment for enrollee characteristics and comorbidities. With decreased durations of Medicaid enrollment, rates of SMM generally increased.
“State Medicaid programs are uniquely positioned to implement strategies that address the burden of SMM among pregnant people with OUD,” the authors write. “Doing so will require early identification of pregnant Medicaid enrollees with OUD and implementation of targeted strategies to increase engagement with perinatal care and SUD treatment.”
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring
Recommendations Issued for Use of Incretin-Based Meds in Pregnancy
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Withdrawal From Medetomidine Increasingly Seen in ICUs
Study Looks at Patient Experiences With Sedative Contaminating Fentanyl
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists
Youth Suicide Risk Linked to Community Firearm Violence